Zachary Roberts Allogene Therapeutics, Inc. (ALLO) insider trading activity

ALLO Quotes by TradingView

Zachary Roberts is EVP of R&D of Allogene Therapeutics, Inc.. Currently has a direct ownership of 661,967 shares of ALLO, which is worth approximately $1.19 Million. The most recent transaction as insider was on Jan 24, 2025, when has been sold 173,913 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 662K
28.47% 3M change
28.47% 12M change
Total Value Held $1.19 Million

Zachary Roberts Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 24 2025
BUY
Grant, award, or other acquisition
-
173,913 Added 20.81%
661,967 Common Stock
Jan 21 2025
SELL
Open market or private sale
$48,414 $1.78 p/Share
27,199 Reduced 5.28%
488,054 Common Stock
Jan 25 2024
BUY
Grant, award, or other acquisition
-
140,000 Added 21.37%
515,253 Common Stock
Jan 22 2024
SELL
Payment of exercise price or tax liability
$78,267 $3.17 p/Share
24,690 Reduced 6.17%
375,253 Common Stock
Mar 22 2023
BUY
Grant, award, or other acquisition
-
148,035 Added 27.01%
399,943 Common Stock
Jan 20 2023
BUY
Grant, award, or other acquisition
-
251,908 Added 50.0%
251,908 Common Stock

Also insider at

TIL
Instil Bio, Inc. Healthcare
Chief Medical Officer
ZR

Zachary Roberts

EVP of R&D
Dallas, TX

Track Institutional and Insider Activities on ALLO

Follow Allogene Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ALLO shares.

Notify only if

Insider Trading

Get notified when an Allogene Therapeutics, Inc. insider buys or sells ALLO shares.

Notify only if

News

Receive news related to Allogene Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ALLO